GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Visiomed Group (XPAR:ALVMG) » Definitions » EV-to-Revenue

Visiomed Group (XPAR:ALVMG) EV-to-Revenue : 4.70 (As of May. 13, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Visiomed Group EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Visiomed Group's enterprise value is €64.36 Mil. Visiomed Group's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was €13.71 Mil. Therefore, Visiomed Group's EV-to-Revenue for today is 4.70.

The historical rank and industry rank for Visiomed Group's EV-to-Revenue or its related term are showing as below:

XPAR:ALVMG' s EV-to-Revenue Range Over the Past 10 Years
Min: -0.12   Med: 1.19   Max: 10.05
Current: 4.7

During the past 13 years, the highest EV-to-Revenue of Visiomed Group was 10.05. The lowest was -0.12. And the median was 1.19.

XPAR:ALVMG's EV-to-Revenue is ranked worse than
63.2% of 826 companies
in the Medical Devices & Instruments industry
Industry Median: 3.265 vs XPAR:ALVMG: 4.70

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-13), Visiomed Group's stock price is €0.202. Visiomed Group's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was €0.04. Therefore, Visiomed Group's PS Ratio for today is 5.32.


Visiomed Group EV-to-Revenue Historical Data

The historical data trend for Visiomed Group's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Visiomed Group EV-to-Revenue Chart

Visiomed Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.88 1.14 1.59 8.53 6.48

Visiomed Group Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.59 - 8.53 - 6.48

Competitive Comparison of Visiomed Group's EV-to-Revenue

For the Medical Instruments & Supplies subindustry, Visiomed Group's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Visiomed Group's EV-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Visiomed Group's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Visiomed Group's EV-to-Revenue falls into.



Visiomed Group EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Visiomed Group's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=64.362/13.706
=4.70

Visiomed Group's current Enterprise Value is €64.36 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Visiomed Group's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was €13.71 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Visiomed Group  (XPAR:ALVMG) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Visiomed Group's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=0.202/0.038
=5.32

Visiomed Group's share price for today is €0.202.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2023 was €0.04.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Visiomed Group EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Visiomed Group's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Visiomed Group (XPAR:ALVMG) Business Description

Traded in Other Exchanges
Address
8, Avenue Kléber, Paris, FRA, 75116
Visiomed Group is engaged in the development, designing, and marketing of medical products. The product portfolio includes various thermometers, natural mud, cold spray, connected activity bracelets, connected scales, inhalers, humidifiers, baby flies, natural wax, comfort foam, antibacterial solutions, baby nutrition, baby accessories, among others.

Visiomed Group (XPAR:ALVMG) Headlines

No Headlines